Navigation Links
Hyaluronic Acid Dermal Filler Market Skyrockets
Date:2/20/2008

The US dermal filler market is expected to grow at a compound annual growth

rate of 20% from 2006-2011, according to Millennium Research Group

WALTHAM, Mass., Feb. 20 /PRNewswire/ -- According to Millennium Research Group's Global Markets for Hyaluronic Acid in Aesthetic, Orthopedic, and Emerging Applications 2008 report, the US hyaluronic acid (HA) dermal filler market will grow at a compound annual growth rate of nearly 20% from 2006 through 2011.

Growth in this market will be driven by a rising demand for dermal filler procedures, performed primarily to correct facial blemishes, and a global population increasingly interested in cosmetic enhancement. HA dermal fillers, the second-most popular facial aesthetic treatment after botulinum toxin (Botox) injections in 2006, will experience very strong growth over the next five years because cosmetic HA injections are quick, safe, effective, and relatively inexpensive.

"Since HA is a naturally occurring compound, many patients are comfortable receiving cosmetic treatments using this product," says Jaya Classen, Senior Analyst at Millennium Research Group. "As a result, it is expected that HA dermal fillers will further penetrate the market at the expense of competing treatments, such as collagen and particle and polymer filler injections."

The Global Markets for Hyaluronic Acid in Aesthetic, Orthopedic, and Emerging Applications 2008 report includes coverage of the HA dermal filler and viscosupplementation markets in the US, Europe (France, Germany, Italy, and the UK), and Asia Pacific (Japan, China, South Korea, and Taiwan). The report provides coverage of all key industry competitors, including Allergan, Fidia Farmaceutici, Genzyme Biosurgery, Medicis Pharmaceuticals, Seikagaku Corporation, and Q-Med.

About Hyaluronic Acid

HA is a compound that is found in human connective tissue. Its degradation in deep and superficial dermal layers has been implicated in the overt signs of aging and, as a major constituent of joint synovial fluid, has been associated with the onset of osteoarthritis. Animal- or synthetically- derived HA supplements can therefore be injected directly in skin for the treatment of wrinkles and scars or into a joint for arthritic pain relief. Furthermore, because HA is naturally found in such a wide variety of tissues, many other potential applications for the compound are emerging.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

akrohn@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. 1st EMEA application filed for product using innovative intradermal microinjection system BD Soluvia
2. PriCara(TM) Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
3. New Study Provides Scientific Evidence That DermaLastyl Face Cream Reduces Wrinkles
4. Building an Effective Sales Force to Serve the U.S. Hospital Market
5. Greenway Medical Technologies Broadens Sales Efforts With Entrance Into Federally Qualified Health Center Marketplace
6. Spectragenics Names Rpr Marketing Communications Agency of Record
7. Northfield Automation Announces Wholly Owned Subsidiary to Diversify Into Medical Device Market
8. Nano Pet Products, LLC Named Exclusive Worldwide Licensee by Schoeller(R) Technologies AG for Pet Products to Develop the Most Technologically Advanced Pet Brands on the Market Today
9. Darwin Enters into Marketing Partnership with Agency Specialty Product Network
10. Healthy Coffee International, Inc. Establishes Healthy Coffee USA, Inc. as Its Marketing Arm
11. A Favorite in France, Elgydium(R) Toothpaste Makes Entrance Into the U.S. Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
Breaking Medicine Technology: